It’s 1995 in the Democratic Republic of Congo, and a man is infected with the Ebola virus. Years later scientists would draw his blood and begin to analyze the antibodies in the sample, hoping to find information leading to a cure for Ebola. Now, the recently published results of this […]
As humans, we often take many things in life for granted, including the ability to breathe. But for many people, this seemingly small capacity is not so minor. Asthma afflicts approximately 300 million worldwide, of which a substantial fraction are children. The condition has no cure and like many chronic […]
A study was recently published which claimed that there is a lack of association between cardiovascular disease (CVD) and total cholesterol; the authors even went on to claim that higher levels of cholesterol may prolong life and suggest that lowering cholesterol via medication is useless. This view is not only extreme, but also garnering a lot of criticism. Statins are commonly prescribed to mitigate symptoms associated with many different disorders, such as hypertension, diabetes and peripheral artery disease (PAD). For now, the jury is out on whether or not the study carries any weight, as a substantial amount of evidence will need to be collected before physicians give up on statins.
For many cancer patients, coping with the consequences of chemotherapy treatment can be as much of a challenge as living with the disease itself. Some potentially useful chemotherapeutic agents are so toxic to healthy cells that they cannot be directly administered to patients. By conjugating these drugs to monoclonal antibodies […]
The issues surrounding psychiatric disorders have long been swept under the rug, but the conversation about mental illness is finally opening up. From classrooms to research labs to the halls of Congress, people are searching for solutions to this public health crisis. Scientists are seeking innovative new treatment options that […]
“Personalized medicine” is an increasingly popular catchphrase in modern health care and advocates of this approach argue that doctors should not assume that one treatment will work for every patient with a certain disease or condition. Instead, it’s believed that doctors should prescribe individualized medical treatments based on an evaluation […]
Imagine if there were a simple blood test for cancer. What if that test could determine the severity of the disease and predict patient outcomes? These musings have challenged researchers in the field of cancer immunomics for decades. Since the 1970’s, scientists have studied cancer biomarkers, hoping to design diagnostic […]
Malaria is caused by the parasite Plasmodium, which infects red blood cells like this one. New research indicates that broadly neutralizing antibodies (bNAbs) may provide effective treatments for malaria and other infectious diseases. Image Source: Flickr Commons Malaria is one of the most widespread and debilitating diseases in the […]
Over the past few years, the medical community’s approach to healthcare has changed. If you’ve visited your primary care physician within the last year or two, no doubt you’ve experienced firsthand the increased emphasis on preventative medicine. Some advice you might have received likely included exercise more, lose weight and watch your diet. With obesity rates in the United States skyrocketing, this renewed focus isn’t surprising—especially in light of the fact that obesity is linked to chronic conditions such as cardiovascular disease and metabolic disorders. One of these chronic diseases is type-2 diabetes, which is initially treated with a regimen similar to the one used to prevent obesity. Due to the connection between the two conditions, the overlap makes sense. In fact, preventing obesity is considered the first step to lowering your chances of developing type-2 diabetes. Like obesity, weight management through diet and exercise isn’t always an effective form of type-2 diabetes treatment. When these methods fail, patients often then turn to other therapies such as medication or insulin shots to control glucose levels. But with the price of insulin rising, there has been an increased interest in finding alternative type-2 diabetes treatment options.
At medical schools and research facilities across the country, physicians and scientists are trying to discover ways to ensure that treatments are more specific and targeted than ever before. Gone are the days when experts are content with a “one-drug-fits-all” style pharmacology. In cancer therapy, these experts are turning to antibody-drug conjugates to serve their needs for specificity in the hope that these therapies will eliminate the often terrible side effects of chemotherapy and result in long-lasting relief from cancer.